Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
NGNE.OQ - Neurogene Inc
Neurogene Inc at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 06:40PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
With the next session. It's my pleasure to host Nero Jean here in this panel, and to my left is founder and CEO Rachel McMinn. What we'll do is continue with what we've done in other panels, which is I'll have Rachel kick it off with an overview and what her strategic priorities are for the remainder of the year.
--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, absolutely. Thanks so much.
It's a very exciting time for NeuroGene. NeuroGene is a clinical stage genetic medicines company. Our lead program is NGN401 for the treatment of Rett syndrome. Just today, we
Trustpilot
